Cargando…
Tanshinone IIA Protects Against Cardiac Hypertrophy via Inhibiting Calcineurin/Nfatc3 Pathway
Pathological cardiac hypertrophy induced by adrenergic overactivation can subsequently develop to heart failure which remains as a leading cause of mortality worldwide. Tanshinone IIA is a lipid-soluble pharmacologically active compound extracted from the rhizome of the Chinese herb Salvia miltiorrh...
Autores principales: | Tan, Xueying, Li, Jianping, Wang, Xinyue, Chen, Nan, Cai, Benzhi, Wang, Gang, Shan, Hongli, Dong, Deli, Liu, Yanju, Li, Xingda, Yang, Fan, Li, Xin, Zhang, Peng, Li, Xueqi, Yang, Baofeng, Lu, Yanjie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076506/ https://www.ncbi.nlm.nih.gov/pubmed/21494433 |
Ejemplares similares
-
Effect of tanshinone IIA on cardiomyocyte hypertrophy and apoptosis in spontaneously hypertensive rats
por: JIANG, F.L., et al.
Publicado: (2013) -
Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca(2+)/Calcineurin/p-NFATc3 Pathway
por: Wang, Xin, et al.
Publicado: (2021) -
Difference of Sodium Currents between Pediatric and Adult Human Atrial Myocytes: Evidence for Developmental Changes of Sodium Channels
por: Cai, Benzhi, et al.
Publicado: (2011) -
Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
por: Zhai, Xifeng, et al.
Publicado: (2017) -
The Complex Regulation of Tanshinone IIA in Rats with Hypertension-Induced Left Ventricular Hypertrophy
por: Pang, Hui, et al.
Publicado: (2014)